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Abstract
Platelet indices (PI) — plateletcrit, mean platelet volume (MPV) and platelet distribution width (PDW) — are a group of derived platelet parame-
ters obtained as a part of the automatic complete blood count. Emerging evidence suggests that PIs may have diagnostic and prognostic value in 
certain diseases. This study aimed to summarize the current scientific knowledge on the potential role of PIs as a diagnostic and prognostic marker 
in patients having emergency, non-traumatic abdominal surgery. In December 2015, we searched Medline/PubMed, Scopus and Google Scholar to 
identify all articles on PIs. Overall, considerable evidence suggests that PIs are altered with acute appendicitis. Although the role of PI in the differen-
tial diagnosis of acute abdomen remains uncertain, low MPV might be useful in acute appendicitis and acute mesenteric ischemia, with high MPV 
predicting poor prognosis in acute mesenteric ischemia. The current lack of consistency and technical standards in studies involving PIs should be re-
garded as a serious limitation to comparing these studies. Further large, multicentre prospective studies concurrently collecting data from different 
ethnicities and genders are needed before they can be used in routine clinical practice.
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Platelets are cytoplasmatic fragments of bone 
marrow megakaryocytes, with a diameter of 3-5 
μm and a volume of 4.5–11 fL (1). A single mega-
karyocyte releases 1500–2000 of them to the 
bloodstream, where they circulate for 7–10 days. 
Inactivated platelets in the blood are discoid 
shaped and do not contain a nucleus. Their cyto-
plasm contains three different types of granules 
(i.e. alpha granules, dense granules, and lysosomal 
granules), secretory vesicles that contain pre-
formed molecules, and a complex membranous 
system (1).
Platelets are dynamic blood particles whose pri-
mary function, along with the coagulation factors, 
is haemostasis, or the prevention of bleeding. 
Platelets interact with each other, as well as with 
leukocyte and endothelial cells, searching the vas-
cular bed for sites of injury, where they become 
activated. When stimulated, platelets undergo a 
shape change, increasing their surface area and bi-
oactive molecules stored within their alpha and 
dense granules’ molecules are rapidly secreted (2).
In addition to their important role in haemostasis 
and thrombosis, accumulating evidence demon-
strates that platelets contribute to the inflamma-
tory process, microbial host defence, wound heal-
ing, angiogenesis, and remodelling (3). Platelets 
release > 300 proteins and small molecules from 
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their granules (chemokines, cytokines like 
interleukin-1β, CD40 ligands, β-thromboglobulin, 
growth factors etc.), which can influence the func-
tion of the vascular wall and circulating immune 
cells (3-6). Platelets also secrete microbicidal pro-
teins and antibacterial peptides (5,7).
Platelets also mediate leukocyte movement from 
the bloodstream through the vessel wall to tissues. 
Platelets are capable of forming reactive oxygen 
species; the oxidative stress that accompanies in-
flammation can also activate platelets (8-10). Plate-
lets’ ability to influence other cells means that they 
can also play many principal roles in the patho-
physiology of diseases.
Platelet indices
Complete blood count (CBC) tests with automated 
haematology analysers are one of the most com-
monly ordered tests in clinical laboratories. Mod-
ern haematology analysers in routine diagnostic 
use, which measure platelet indices (PIs), use im-
pedance counting or optical light scatter counting 
techniques. The measurement principle influences 
the results, and the results from different analysers 
are not comparable (11).
Platelet count in the blood can be rapidly meas-
ured using an automated haematologic analyser. 
Platelet indices are biomarkers of platelet activa-
tion. They allow extensive clinical investigations 
focusing on the diagnostic and prognostic values 
in a variety of settings without bringing extra 
costs. Among these platelet indices, plateletcrit 
(PCT), mean platelet volume (MPV), and platelet 
distribution width (PDW) are a group of platelet 
parameters determined together in automatic 
CBC profiles; they are related to platelets’ mor-
phology and proliferation kinetics (Table 1). 
The volume of platelets in the bloodstream is het-
erogeneous, and their structures and metabolic 
functions differ. Typically, the average mean cell 
volume is 7.2–11.7 fL in healthy subjects (12,13). In 
MPV, the analyser-calculated measure of thrombo-
cyte volume is determined directly by analysing 
the platelet distribution curve, which is calculated 
from a log transformation of the platelet volume 
distribution curve, to yield a geometric mean for 
this parameter in impedance technology systems. 
In some optical systems, MPV is the mode of the 
measured platelet volume (14). MPV is determined 
in the progenitor cell, the bone marrow megakar-
yocyte. The platelet volume is found to be associ-
ated with cytokines (thrombopoietin, interleu-
kin-6 and interleukin-3) that regulate megakaryo-
cyte ploidy and platelet number and result in the 
production of larger platelets (15-17). When plate-
let production is decreased, young platelets be-
come bigger and more active, and MPV levels in-
crease. Increased MPV indicates increased platelet 
diameter, which can be used as a marker of pro-
duction rate and platelet activation. During activa-
tion, platelets’ shapes change from biconcave 
discs to spherical, and a pronounced pseudopod 
formation occurs that leads to MPV increase dur-
ing platelet activation. 
Parameter Description Unit
Mean platelet volume (MPV) Analyser-calculated measure of thrombocyte volume femtoliters (fL)
Platelet volume distribution width (PDW) Indicator of volume variability in platelets size percentage (%)
Plateletcrit (PCT) Volume occupied by platelets in the blood percentage (%)
Mean platelet component (MPC) Measure of mean refractive index of the platelets gram/decilitre (g/dL)
Mean platelet mass (MPM) MPM is calculated from the platelet dry mass histogram picogram (pg)
Platelet component distribution width (PCDW) Measure of the variation in platelet shape gram/decilitre (g/dL)
Platelet larger cell ratio (P-LCR) Indicator of larger (> 12 fL) circulating platelets percentage (%)
Immature platelet fraction (IPF)  Percentage of immature platelets percentage (%)
Table 1. Platelet indices
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PDW is an indicator of volume variability in plate-
lets size and is increased in the presence of plate-
let anisocytosis (17). PDW is a distribution curve of 
platelets measured at the level of 20% relative 
height in a platelet-size distribution curve, with a 
total curve height of 100% (18). The PDW reported 
varies markedly, with reference intervals ranging 
from 8.3 to 56.6% (12,19-21). PDW directly meas-
ures variability in platelet size, changes with plate-
let activation, and reflects the heterogeneity in 
platelet morphology (13,20). Under physiological 
conditions, there is a direct relationship between 
MPV and PDW; both usually change in the same 
direction (20). Meanwhile, there are conflicting re-
ports in the literature about the relationship be-
tween platelet volume and numbers, which sug-
gests that they are affected by different mecha-
nisms (5,21-25).
PCT is the volume occupied by platelets in the 
blood as a percentage and calculated according to 
the formula PCT = platelet count × MPV / 10,000 
(25-27). Under physiological conditions, the 
amount of platelets in the blood is maintained in 
an equilibrium state by regeneration and elimina-
tion. The normal range for PCT is 0.22–0.24% 
(13,25-27). In healthy subjects, platelet mass is 
closely regulated to keep it constant, while MPV is 
inversely related to platelet counts (6,13,27). Ge-
netic and acquired factors, such as race, age, smok-
ing status, alcohol consumption, and physical ac-
tivity, modify blood platelet count and MPV (27-
29).
Platelet larger cell ratio (P-LCR) is an indicator of 
circulating larger platelets (> 12 fL), which is pre-
sented as percentage. The normal percentage 
range is 15–35%. It has also been used to monitor 
platelet activity (30).
Mean platelet component (MPC) is a measure of 
mean refractive index of the platelets by modified 
two-angle light scatter and it is useful in determin-
ing changes in the status of platelet activation. 
Platelet component distribution width (PCDW) 
and mean platelet mass (MPM) are new platelet 
activation parameters measured by the Siemens 
Advia 120 haematology analyser. 
Immature platelet fraction (IPF) indicates the per-
centage of immature platelets, as a percentage of 
the total platelet population measured in the re-
ticulocyte/optical platelet channel of the haema-
tology analyser by flow cytometry, in which dye 
penetrates the cell membrane, staining the RNA in 
the cytoplasm of immature (or reticulated) plate-
lets on the Sysmex XE-2100 analyser (Sysmex Cor-
poration, Kobe, Japan). The IPF percentage in-
creases as production of platelets increases, and 
low values indicate suppressed thrombopoiesis (31).
The clinical significance, reference values and use-
fulness of some of these parameters are still under 
investigation (32).
Platelet indices as diagnostic and 
prognostic markers
Simultaneous measurement of all of the platelet 
indices will provide us a valid instrument for meas-
uring disease severity and an insight into the po-
tential etiology that resulted in platelets’ indices 
changes. Platelet volume heterogeneity occurs 
during its production and increases MPV and PDW 
comparatively, suggesting that bone marrow pro-
duces platelets and rapidly releases them into cir-
culation (18). A simultaneous reduction of platelet 
count and PCT indicates that platelets have been 
excessively consumed (33).
Platelets play an important role in inflammation, 
and recently, several additional functions for plate-
lets in the process of inflammation were defined. A 
substantial number of studies have demonstrated 
crucial roles for platelets in the pathogenesis of 
various inflammatory clinical conditions where in-
flammation is important (34). Numerous research 
groups have found a relationship between the 
changes in platelet indices and the activation of 
the coagulation system, severe infection, trauma, 
systemic inflammatory reaction syndrome, and 
thrombotic diseases (34). Platelet indices have 
been shown to have diagnostic value in certain in-
flammatory diseases, such as inflammatory bowel 
diseases, rheumatoid arthritis, ankylosing spondy-
litis, ulcerative colitis, and atherosclerosis (6,34-39). 
http://dx.doi.org/10.11613/BM.2016.020 Biochemia Medica 2016;26(2):178–93 
  181
Ustundag Budak Y. et al. The use of platelet indices in abdominal surgery
MPV acts as a negative or positive acute phase re-
actant in different inflammatory conditions. High 
MPV levels are associated with high-grade inflam-
mation owing to the presence of the large plate-
lets in circulation. MPV might decrease in high-
grade inflammation due to the consumption and 
sequestration of these large platelets in the vascu-
lar segments of the inflammatory region. Low MPV 
is associated with low-grade inflammation, like 
rheumatoid arthritis and attacks of familial Medi-
terranean fever. MPV decreases and increases in 
acute and chronic disorders, respectively (6).
MPV shows the activity of disease in systemic in-
flammation, acute pancreatitis, unstable angina, 
and myocardial infarction (40-43). MPV can be a 
modifiable marker in identifying patients with ac-
tive ankylosing spondylitis and rheumatoid arthri-
tis, which is thought to be due to increased con-
sumption of platelets in the inflammation area and 
MPV increases with therapy in these patients 
(37,44). 
Sepsis is another example of obvious interaction 
between the immune and haemostatic system. 
Since these systems are closely linked, septic pa-
tients are observed to have low platelet count due 
to production of many cytokines, endothelial 
damage and bone marrow suppression. In pa-
tients with septic shock, the rise in MPV, and to a 
lesser extent an increase in P-LCR and PDW, indi-
cates a worse prognosis (6,45,46).
In the emergency department, surgeons frequent-
ly use CBC to determine inflammatory pathologies 
and as part of routine preoperative assessment. 
Platelet indices especially MPV, may be a simple 
way to provide valuable information during rou-
tine blood counts without increasing the cost of 
diagnosis or differentiating non-traumatic abdom-
inal surgery patients. 
To date, there has been no published meta-analy-
sis of the potential use of PIs in emergency non-
traumatic abdominal surgery. In addition, there 
has been only one published meta-analysis of the 
value of MPV as a predictor of cardiovascular risk, 
by Chu et al. (43). This review aimed to summarize 
current scientific knowledge of the potential role 
of PIs as a diagnostic and prognostic marker in 
emergency non-traumatic abdominal surgery pa-
tients, especially those with acute appendicitis, 
acute cholecystitis and acute mesenteric ischemia. 
Methods
In December 2015, we searched Medline/PubMed, 
Scopus and Google Scholar for ‘platelet’, ‘platelet 
indices’, ‘platelet distribution width’, ‘plateletcrit’, 
PCT, ‘mean platelet volume’ and ‘MPV’ in combina-
tion with ‘surgery’, ‘acute appendicitis’, ‘acute chol-
ecystitis’ and ‘acute mesenteric ischemia’, identify-
ing a number of studies. Then, we sequentially 
screened titles, abstracts and full-text articles to 
identify all relevant articles published in English. 
We reviewed reference lists to identify further lit-
erature references to eligible studies. Studies were 
included in this review if they were published in a 
peer-reviewed journal and included human sub-
jects. Both retrospective and prospective studies 
were considered for this review whereas case re-
ports were excluded. We set no age limits. Power 
analysis has not been performed in any of these 
studies. All data (from 24 studies) are presented 
systematically and summarized in Table 2. 
Acute appendicitis and platelet 
parameters
Acute appendicitis is defined as inflammation of 
the of the appendix vermiformis, and usually caus-
es pain in the right lower abdominal quadrant that 
is the most common cause of acute abdomen in 
all age groups attending to emergency settings 
(47). Appendectomy is the most frequently per-
formed surgery in the emergency surgery clinics. 
It is important to diagnose acute appendicitis be-
fore complications occur because diagnostic delay 
considerably increases the risk of appendicitis per-
foration.
Although in some patients the symptomatology 
and examination findings are classic, it is hard to 
diagnose in patients with less specific signs with 
abdominal pain; a number of diseases mimic ap-
pendicitis. It is often difficult to rule it out on the 
basis of clinical presentation, and requires further 
investigation to diagnose correctly. On the other 
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hand, the entity of negative appendectomies is 
14.7% to 8.47% of abdominal exploration surgery, 
and negative appendectomy is associated with 
unnecessary risks and costs to patients (47,48).
Clinical history, physical exam with ultrasonogra-
phy, computed tomography, and magnetic reso-
nance imaging have been shown to contribute to 
diagnostic accuracy in patients with suspected 
acute appendicitis, but not all the time. There has 
been much effort to search for biomarkers to iden-
tify patients at risk for appendicitis; however, most 
of them are expensive and unavailable in most 
emergency departments, and there is difficulty in 
making an accurate diagnosis of appendicitis (49). 
Therefore, as cheap and available diagnostic mark-
ers, inflammation-related CBC parameters, white 
blood cell (WBC) count, and neutrophil percent-
age are the most frequent markers of inflamma-
tion used in diagnosis, and are the earliest indica-
tors in showing inflammation of appendicitis (49). 
None are diagnostic of acute appendicitis and 
their sensitivity and specificity ranges vary widely 
and are dependent upon the population under 
study, symptom time duration and cut-off values 
used (50,51). Given the limitations of the current 
inflammatory markers, surgeons are searching for 
other potential biomarkers for the diagnosis of 
acute appendicitis to decrease the rate of negative 
laparotomies in cases with a pre-diagnosis of acute 
appendicitis, so as to lead to fewer delays in diag-
nosis and the early prediction of perforation 
(52,53). In order to increase the accuracy of acute 
appendicitis detection, some researchers have 
been directed towards using platelet parameters 
in addition to WBC, which is easily applicable eve-
rywhere, cheap, and non-invasive, and would not 
cause a loss in diagnostic time.
Studies investigating PIs as biomarkers of 
acute appendicitis patients
Some of these studies suggested MPV alteration 
as a valuable diagnostic marker, but the alteration 
of MPV in acute appendicitis is controversial. Sev-
en retrospective case control studies stated that 
the MPV was lower in acute appendicitis patients 
than in healthy controls (54-60), whereas one 
study reported the opposite finding (61). Two stud-
ies showed no significant difference between the 
two groups in adult patients (62,63). The general 
properties of these studies are shown in Table 2. 
All except one were retrospective, and acute ap-
pendicitis diagnosis was confirmed histopatholog-
ically and the control group was composed of dis-
tinct patients with no symptoms, including pa-
tients admitted to outpatient centres for routine 
exams. The analysers used were different, and in 
some studies, it was not indicated which analyser 
was used. This may introduce bias into certain 
study designs.
Yang et al. found that, when groups of patients di-
agnosed with acute appendicitis were subdivided 
according to gender, only the male group showed 
a statistically significant decrease in MPV (P = 0.009) 
(58). This study was in accordance with Lee at al., 
which stated that PIs are not useful in distinguish-
ing acute appendicitis from normal populations in 
female candidates (63).
In the study by Kucuk and Kucuk, control and 
acute appendicitis group data were obtained from 
the same patients, and no intra-individual differ-
ence between patients in terms of MPV was found. 
Previous MPV values corresponding to the non-in-
flammatory state were determined from these pa-
tients’ medical records in the hospital database. 
They found that MPV was significantly lower rela-
tive to non-diseased stages. Receiver operating 
characteristic curve analysis suggested that the 
optimal cut-off point for the diagnosis of acute ap-
pendicitis was 6.10 fL, with a sensitivity of 83% and 
a specificity of 42% (64).
Kılıç et al. could not find a difference between 
acute appendicitis and patient groups, and sug-
gested that MPV could have been affected by an 
inflammatory process other than appendicitis. 
They considered this the most important factor re-
sulting in no significant difference in MPV be-
tween acute appendicitis patients and controls in 
their study (65).
Meanwhile, a study conducted by Narci et al. sug-
gested that higher MPV values might guide the di-
agnosis of acute appendicitis, with 66% sensitivity 
and 51% specificity (61). 
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Table 2. Summary of studies (continued)
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Some of the studies evaluated the PIs among the 
groups who underwent appendectomy with a 
pre-diagnosis of acute appendicitis without in-
cluding healthy control groups (63,66,67). Aktimur 
et al. analysed 469 patients who underwent ap-
pendectomy; in 408 of the patients, the diagnosis 
was confirmed by histopathological assessment, 
and in 61 patients, the appendix were normal. 
They found that MPV values were higher in the 
acute appendicitis group compared to negative 
appendectomies (66).
Bozkurt et al. compared MPV results of uncompli-
cated acute appendicitis, complicated acute ap-
pendicitis (perforated, plastrone, necrotising ap-
pendicitis, and appendicitis with peritonitis), and 
non-appendicitis (normal appendix, reactive 
lymph node hyperplasia) cases that underwent 
appendectomy. Although the complicated appen-
dicitis group had a lower MPV value compared to 
other groups, the levels were not statistically dif-
ferent across the groups (62).
Aydogan et al. separated acute appendicitis pa-
tients into two groups according to perforation 
status. MPV was lower and PDW was higher in the 
perforated group than in the non-perforated 
group (67).
Ceylan et al. separated 362 acute appendicitis pa-
tients into two groups and found that MPV was 
lower in subjects without complications compared 
to subjects with complications and the control 
group. PDW did not differ between groups (59).
Saxena et al. attempted to define potential thresh-
old values that are predictive of a diagnosis. When 
they used a cut-off value of MPV < 7.6 fL, they 
found sensitivity, specificity, and accuracy of 
83.73%, 75%, and 83.56%, respectively (68).
Acute appendicitis is the most common surgical 
condition in children that causes acute abdominal 
pain, but its diagnosis can be extremely difficult 
due to its vague signs and symptoms, and is thus 
at high risk of being misdiagnosed. In addition to 
limited communication skills, young children pose 
a diagnostic challenge due the non-specific nature 
of their symptoms; therefore, more laboratory 
data are needed to clarify the diagnosis of patients 
with suspected appendicitis. PIatelets as laborato-
ry inflammatory markers have been studied, but 
the results are contradictory. Bilici et al. found that, 
in paediatric acute appendicitis patients of 1–15 
years old, MPV levels were markedly low com-
pared to the healthy control group (69). On the 
other hand, Uyanik et al. failed to find a difference 
in MPV levels between paediatric acute appendici-
tis patients and the control group (70). They sug-
gested that the destruction of erythrocytes in 
acute inflammation may cause fragmented cells to 
be counted as thrombocytes, thus leading to a 
false MPV decrease. Yılmaz et al. analysed 204 
pediatric patients operated on for a preliminary di-
agnosis of acute appendicitis, of which 20 subjects 
had normal appendix vermiformis. They found 
that there is no difference with regard to the PIs 
between the children with true appendicitis (MPV, 
PCT,and PDW) and those with a normal appendix 
(71). 
However, a number of issues must be considered 
when translating measurement of the PIs of ap-
pendicitis patients into clinical practice in the 
emergency setting. PI results are influenced by 
factors such as the anticoagulant used in the col-
lection tube, the delay in time from sampling to 
analysis and the individual technologies devel-
oped for each type of analyser (72). In light of 
these findings, we excluded studies that did not 
report the time from the phlebotomy until the 
analysis or the analyser on which the PIs were 
measured. Only five studies fit these reporting cri-
teria. In all of these studies, MPV values were low 
in acute appendicitis patients compared to healthy 
controls (54,58,59,65,69).
Acute cholecystitis
Acute cholecystitis is an acute inflammatory dis-
ease of the gallbladder with an abrupt onset in 
hours. In most of the cases, the underlying aetiol-
ogy is gallstone. With early diagnosis and therapy, 
mortality and morbidity are lowered. Ultrasonog-
raphy is the most important method in diagnosis, 
with a sensitivity of 80% to 100% and specificity of 
60% to 100%. C-reactive protein (CRP), erythrocyte 
sedimentation rate (ESR), and WBC support the di-
agnosis (73,74). Early diagnosis and treatment of 
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patients is very important because, if not treated, 
acute cholecystitis has a high mortality rate (75).
Recently, two retrospective studies investigated 
MPV as a biomarker of acute cholecystitis. Sayit et 
al. evaluated 60 patients with a diagnosis of acute 
cholecystitis, using medical records. Also, the data 
of 60 age-matched, healthy individuals with nor-
mal abdominal ultrasound were evaluated as the 
control group. They found the MPV levels in pa-
tients with acute cholecystitis significantly lower, 
and PDW and PCT significantly higher in the acute 
cholecystitis group when compared to the control 
group (75). Seker et al. analysed 33 patients with 
acute cholecystitis and 32 patients with chronic 
cholecystitis, and 28 healthy individuals. MPV val-
ues were found to be significantly lower in the 
acute cholecystitis group when compared to those 
in the chronic cholecy stitis and control groups (P 
< 0.05) (74).
Because we found only two retrospective studies, 
each with a small number of patients, there is a 
need for larger, prospective, well-designed studies 
in various settings to measure the potential of PIs 
in acute cholecystitis patients.
Acute mesenteric ischemia
Acute mesenteric ischemia is a syndrome caused 
by a significant decrease in mesenteric blood flow 
that results in ischemia and eventual bowel necro-
sis, with an overall mortality rate of 40–70%. The 
causes of mesenteric vascular ischemia are embo-
lism, thrombosis and mesenteric venous thrombo-
sis (76,77). Definitive diagnosis can be made by ad-
vanced imaging modalities, such as computerized 
tomography or invasive angiographic evaluations 
in conjunction with expert radiologic interpreta-
tion, but these techniques are not always available 
in emergency conditions.
Patients with suspected acute mesenteric is-
chemia are more prone to complications, such as 
peritonitis and sepsis. Early diagnosis and surgical 
correction of blood circulation to prevent bowel 
necrosis and early resection of necrotised intesti-
nal segments as soon as possible prior to sepsis 
may reduce the hospital mortality rate; this is the 
best way to decrease the mortality rate in patients 
with acute mesenteric ischemia (77,78). The surviv-
al rate has not improved; the major reason for this 
is the continuing difficulty in recognizing the con-
dition before bowel infarction occurs; this is due to 
delayed presentation, nonspecific clinical findings 
and a lack of routine biochemical markers (77,78).
A number of biochemical parameters are being in-
vestigated for early diagnosis, but because they 
are associated with other diseases and their sensi-
tivities are low, these serum markers are still con-
troversial. There is no sufficiently sensitive or spe-
cific marker to guarantee diagnosis of acute mes-
enteric ischemia. Excessive inflammation and in-
fection in acute mesenteric ischemia has led re-
searchers to investigate inflammation-related CBC 
parameters to predict acute mesenteric ischemia 
in suspected patients (79,80). Among them, MPV 
was studied separately in acute mesenteric is-
chemia.
Türkoğlu et al. evaluated a total of 95 patients who 
underwent emergency surgery for acute mesen-
teric ischemia and 90 healthy volunteers as control 
group. They found MPV values to be significantly 
higher in patients with acute mesenteric ischemia 
than in the controls (81). MPV is evaluated in a 
number of studies for prediction of prognosis in 
acute mesenteric ischemia patients. Altintoprak et 
al. suggested that high MPV can show vascular 
damage in the liver and kidneys and predisposi-
tion to thrombosis, and can be used for re-opera-
tion and to discriminate patients with bad throm-
bosis. They concluded that MPV values at presen-
tation were higher among non-survivors than sur-
vivors, and might be beneficial in predicting pa-
tients with poor prognosis and in the planning of 
re-operations. The ready availability of this param-
eter at no additional cost may encourage its utili-
zation in clinical practice (82). In contrast, Aktimur 
et al. stated that MPV demonstrated significant 
prognostic difference in surviving patients with 
acute mesenteric ischemia. WBC and MPV values 
were higher in the acute mesenteric ischemia 
group than the control group with a normal ap-
pendix which were operated according to wrong 
pre-diagnosis as an acute appendicitis. They found 
higher MPV values in surviving patients in a rela-
tively larger study group (83).
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Bilgiç et al. studied 61 acute mesenteric ischemia 
patients divided into two groups, survivors and 
non-survivors, according to the outcome, and the 
two groups were compared in terms of MPV levels 
and other prognostic factors. They found signifi-
cantly higher MPV levels in the non-survivor 
group. ROC curve analysis suggested that the best 
MPV level cut-off points for acute mesenteric is-
chemia was 8.1 fL, with sensitivity, specificity, and 
positive and negative predictive values (PPV and 
NPV) of 60, 73.1, 74.7, and 58%, respectively. The 
likelihood ratio was 2.23 (95% CI: 1.1–4.4) for this 
cut-off MPV level. Their results indicate that an el-
evated MPV is associated with a worse outcome in 
patients with acute mesenteric ischemia (84).
According to the studies mentioned above, high 
MPV levels on admission might explain the in-
creased mortality rate and severity of acute mes-
enteric ischemia.
Publication bias and heterogeneity
The present review has limitations that come from 
the limitations of the included studies. First, be-
cause of the retrospective nature of these studies, 
the interval between symptom onset and blood 
testing was not reported in these studies. Addi-
tionally, the time between blood collection and 
analysis time was not standardized between stud-
ies. Both are important in the evaluation of PIs. No-
tably, the method of venipuncture and the degree 
of accuracy of filling and mixing the sampling 
tubes may cause platelet activation and result in 
some of the pre-analytical variables that affect re-
sults, which may lead to bias between studies.
Platelet indices change continuously at room tem-
perature depending on the anticoagulant used / 
the method of analyser (85-89). Most researchers 
recommend measuring PIs within one hour re-
gardless of anticoagulant, which is not indicated in 
most of the studies (88). Although ethylenediami-
netetraacetic acid (EDTA) is accepted as the refer-
ence method in clinical settings (13), it causes 
time-dependent ultrastructural morphological 
changes, leading to modification from a discoidal 
to a spherical shape in platelets (85).
In the literature, discrepancies between PIs come 
out in the current laboratory practice by a lack of 
harmonization across the different analysers. The 
measurement technique (impedance or optical) 
and the calibration of the haematology analyser 
can lead to variations (89). When different technol-
ogies were compared, there were no significant 
differences for platelet count, but PIs differed. The 
current lack of harmonization should be regarded 
as a serious limitation for comparability of PIs ob-
tained with different haematological analysers.
On the other hand, when advocating the use of PIs 
as a clinical diagnostic tool in acute appendicitis, 
the PIs offer several advantages. They do not add 
any cost for the patient, since it is part of a stand-
ard CBC, adds a low testing burden on clinicians 
and patients.
In conclusion, increasing and convincing evidence 
shows that use of platelet indices as a marker for 
non-traumatic abdominal surgery in emergency 
settings carries some clinical and practical advan-
tages. Although the role of PI in the differential di-
agnosis of non-traumatic abdominal surgery pa-
tients remains uncertain, in addition to other 
markers, low MPV might be useful in acute appen-
dicitis and acute cholecystitis, and high MPV might 
be useful in predicting poor prognosis in acute 
mesenteric ischemia.
Despite the large number of studies and the rela-
tive ease with which PIs can be obtained, PIs are 
not routinely used in clinical practice because, in 
particular, PIs are not specific for (or predictive of) 
any particular pathological condition, and there is 
a considerable bias among studies, revealing a 
need for more high-quality epidemiological stud-
ies. A uniformity of measurement should be used 
to make the results comparable with each other. 
Further large, multicentre prospective studies con-
currently collecting data from different ethnicities 
and genders are needed before they can be used 
in everyday clinical practice.
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